Episode 5: Obesity Drugs - Game Changers or Overhyped?

Are GLP-1 weight loss drugs like Ozempic the miracle cure they are made out to be on social media, or are they simply overhyped? In this episode of the ASSA Clarity podcast, host Lucienne Fild sits down with Desigan Pillay, a member of the Actuarial Society of South Africa, to unpack the rapid rise of metabolic health advancements and what they mean for the insurance and actuarial landscapes. Desigan breaks down the three buckets of metabolic health and shares unique insights into South Africa’s distinct obesity demographics. The discussion dives deep into the realities of long-term usage - touching on drug adherence, "yo-yo" usage, muscle and bone mass loss, and the socioeconomic "haves and have-nots" of healthcare access. Finally, they explore the direct operational impacts for life, health, and disability insurers. Tune in for an insightful, data-driven conversation on whether the actuarial profession is ready for the GLP-1 revolution.